OPIOID PEPTIDES: RECEPTORS, BIOSYNTHESIS, AND RELEASE

Information

  • Research Project
  • 3206808
  • ApplicationId
    3206808
  • Core Project Number
    R01DA000662
  • Full Project Number
    5R01DA000662-10
  • Serial Number
    662
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1973 - 51 years ago
  • Project End Date
    3/31/1986 - 39 years ago
  • Program Officer Name
  • Budget Start Date
    4/1/1985 - 40 years ago
  • Budget End Date
    3/31/1986 - 39 years ago
  • Fiscal Year
    1985
  • Support Year
    10
  • Suffix
  • Award Notice Date
    -
Organizations

OPIOID PEPTIDES: RECEPTORS, BIOSYNTHESIS, AND RELEASE

OBJECTIVES: 1. To continue the investigation into the physiological roles of the endogenous opioid peptides, methionine-enkephalin, leucine-enkephalin and beta-endorphin. 2. To continue with the characterization of the binding of opiates and opioid peptides to mu-, delta- and kappa-receptor sites. To search for agonists and antagonists which interact specifically with each type of these receptors. 3. To use specific agonists or antagonists for the study of the differential distribution of the various opiate receptors in the central and peripheral nervous system of various species. 4. To continue to study the mechanisms mediating the release of the enkephalins and to examine the differences in the release of methionine-and leucine-enkephalin. To investigate the modulation of release by drugs. 5. To study the biosynthesis of the two enkephalins and, in particular, the kinetics of the interactions between the enkephalins and their putative precursors. 6. To continue to assess the agonist and antagonist characteristics of new synthetic narcotic analgesic drugs and to pay special attention to their differential interactions with the mu, delta, and kappa-receptors. 7. To continue the investigation of the role of the interaction between the endogenous opioid peptides and exogenously applied narcotic analgesics in the development of tolerance and dependence.

IC Name
NATIONAL INSTITUTE ON DRUG ABUSE
  • Activity
    R01
  • Administering IC
    DA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    DABR
  • Study Section Name
    Pharmacology I Research Subcommittee
  • Organization Name
    UNIVERSITY OF ABERDEEN
  • Organization Department
  • Organization DUNS
    212381045
  • Organization City
    ABERDEEN
  • Organization State
  • Organization Country
    UNITED KINGDOM
  • Organization Zip Code
    AB24 3FX
  • Organization District
    UNITED KINGDOM